Management of Patients under Treatment with Monoclonal Antibodies and New Biological Therapies
Loading...
Official URL
Full text at PDC
Publication date
2021
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
Citations
Exportar
Citation
Amigo-Basilio, M.; Álvarez-González, C.; Cobo-Vázquez, C.; Leco-Berrocal, I.; Sáez-Alcaide, L.M.; Méniz-García, C. Management of Patients under Treatment with Monoclonal Antibodies and New Biological Therapies. Appl. Sci. 2021, 11, 4865. https://doi.org/10.3390/ app11114865
Abstract
Objective: The aim of this study is to know the biological therapy drugs that are related to adverse events, what dental treatments are associated with the appearance of these events, their severity, and how they are resolved.
Study design: Analysis of cases described in the literature on patients undergoing treatment with biological therapies who have developed adverse effects associated with these drugs. Results: Of the 62 articles reviewed, 49 describe 68 cases of MRONJ, most of which appeared in the jaw and received surgical and/or conservative treatment.
Conclusions: Biological therapies can potentially develop adverse effects in the oral cavity, so strict monitoring by the dentist is necessary.